June Deals - A Quiet Month For Medtech
Executive Summary
June saw sparse dealmaking activity in the pure device/diagnostics sectors, with much more spent in the medical software segment instead. Have a look below at this month's Medtech Insight dealmaking highlights, as well as a table of deals recorded by Biomedtracker that shows less than $700m was spent on pure device/diagnostics deals.